11th Annual Drug Discovery for Neurodegeneration Conference 2017

The 11th Annual Drug Discovery for Neurodegeneration Conference 2017 is dedicated to developing new drugs to treat and prevent neurodegenerative diseases.

Topics

• Fundamentals of medicinal chemistry relevant to drug discovery for neurodegenerative diseases
• Challenges and opportunities in academic drug discovery
• Go-no-go criteria for preclinical development, including pharmacokinetic behavior of candidate compounds, aqueous solubility, blood-brain barrier permeability, preliminary safety, and manufacturing issues
• Newest trends in assay development and high throughput screening (HTS)
• Biologics for challenging CNS targets and strategies to optimize brain delivery
• Study design considerations for animal model experiments
• Commercialization strategies for developing science into products
• Requirements for an Investigational New Drug (IND) application
• Funding & resources for preclinical therapeutics development for neurological disorders
• Best practices for working with tech transfer offices, managing intellectual property, and the role of funding organizations

Who should Attend

• Business development and licensing professionals
• Academic and industry scientists engaged in drug discovery research for neurodegenerative disease or CNS
• Young investigators and graduate students
• Alliance management professionals